BEAM 240816 27.00P (BEAM240816P27000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BEAM240816P27000

Watchlist

2.30
-1.22-34.66%

15min DelayClose Aug 16 15:59 ET

2.30High2.30Low

Intraday

5D
Daily

News

Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
BenzingaAug 14 14:21 ET
Beam Therapeutics Inc. (BEAM): Pioneering Genetic Medicine With CRISPR Technology
Yahoo FinanceAug 14 10:27 ET
Analysts Are Bullish on Top Healthcare Stocks: Beam Therapeutics (BEAM), Taysha Gene Therapies (TSHA)
TipRanksAug 14 05:04 ET · Ratings
Beam Therapeutics: Hold Rating With Stable Financial Outlook Amid Clinical Pipeline Progress and Upcoming Data Releases
TipRanksAug 9 05:59 ET · Ratings
Beam Therapeutics Price Target Cut to $31.00/Share From $33.00 by Barclays
Dow JonesAug 7 12:48 ET · Ratings
Beam Therapeutics Is Maintained at Equal-Weight by Barclays
Dow JonesAug 7 12:48 ET

Comments

ClydePeternuts

Jul 17 03:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics (BEAM.US)$ $Oklo Inc (OKLO.US)$
Sells🔴\\ $Zoom Video Communications (ZM.US)$ $Trimble (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

PaulG

Feb 27 14:10

$Beam Therapeutics (BEAM.US)$ Will double to 90 dollars 💸 💵 💲

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Dec 14, 2023 05:35

Beam Therapeutics' CEO, John Evans showed confidence in Ms. Shaw's ability to turn scientific innovations into commercial treatments. Shaw recognizes Beam's groundbreaking work in genetic medicine and gene editing, predicting major clinical milestones ahead thanks to the company's comprehensive platform and capabilities.

Press Release: Beam Therapeutics Appoints Biotech Executive Christi Shaw to Its Board of Directors